By Michael Nevradakis, Ph.D. | The Defender | October 18, 2024 The National Institute of Allergy and Infectious Diseases (NIAID) this week announced Bavarian Nordic’s mpox (monkeypox) vaccine is “safe and generates a robust antibody response in adolescents.” The announcement drew criticism from doctors and scientists who cited the lack of any evident control group in […]
NIAID Declares Mpox Vaccine ‘Safe’ for Teens, Opening the Door for Vaccine’s Approval for Kids as Young as 12
The Free 